The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma

BACKGROUND: Basal cell carcinoma is the commonest human cancer. Despite increasing incidence it remains poorly researched. While not life threatening it can cause significant cosmetic disfigurement. Imiquimod, a cream which enhances the body's immune response, may help deal with the number of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozolins, Mara, Williams, Hywel C, Armstrong, Sarah J, Bath-Hextall, Fiona J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877028/
https://www.ncbi.nlm.nih.gov/pubmed/20409337
http://dx.doi.org/10.1186/1745-6215-11-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877028/
https://www.ncbi.nlm.nih.gov/pubmed/20409337
http://dx.doi.org/10.1186/1745-6215-11-42

Ejemplares similares